Genome-Wide-Association-Studies (GWAS) have shown that SNPs in the second intron of the FGFR2 gene are significantly associated with high risk of breast cancer, in particular in post-menopausal women [105,203–205], confirming an oncogenic role for FGFR2. The gene discussed is FGFR2; the disease is breast carcinoma.